Pediatric asthma and COVID-19: The known, the unknown, and the controversial

44Citations
Citations of this article
187Readers
Mendeley users who have this article in their library.

Abstract

The novel coronavirus disease-2019 (COVID-19), caused by the pathogen severe acute respiratory syndrome-CoV-2, is causing a global pandemic, with over 26.9 million cases and 880,000 deaths as of September 6, 2020. While there has been speculation and observational research about the impact of COVID-19 on asthma, much remains unknown. The goal of this article is to provide a scoping review on pediatric asthma and COVID-19 and summarize what we do and do not know from the first wave of the pandemic.

Cite

CITATION STYLE

APA

Abrams, E. M., Sinha, I., Fernandes, R. M., & Hawcutt, D. B. (2020). Pediatric asthma and COVID-19: The known, the unknown, and the controversial. Pediatric Pulmonology, 55(12), 3573–3578. https://doi.org/10.1002/ppul.25117

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free